DNR.NPC T-cells

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameDNR.NPC T-cells
Drug Alias Namegenetically engineered autologous cell therapy (St Jude Children's Research Hospital)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionTransforming growth factor beta receptors modulators
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsNasopharyngeal Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSt. Jude Children'S Research Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSt. Jude Children'S Research Hospital
Inactive CompaniesN/A
Active IndicationsNasopharyngeal Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A